On January 29, Archivel Farma, represented by its CEO, Olga Rúe, and Dr. Pere Joan Cardona, scientific advisor to the company, participated in the annual meeting of the Tuberculosis Vaccine…
Read More
Olga Rue, CEO of Archivel Farma, and Dr Pere Joan Cardona, Scientific advisor of the company, participated in the inauguration meeting of the Horizon 2020 project STriTuVaD (In Silico Trial…
Archivel Farma is one of the eight partners of STriTuVad consortium, whose overall goal is to demonstrate how advanced computer modelling and simulation can be used to reduce the costs…
Archivel Farma has decide to launch its new website to coincide with the World TB Day 2018 (March 24) as a way of reminding the importance of awareness to continue…
Archivel Farma is supporting a year more the activities organized in Barcelona around the World TB Day, which the United Nations instituted on March 24 (commemorating the date on which…
TGT Group, a strategic partner of Archivel Farma since January 2012, has increased its participation in the company from 49% to 53% after subscribing two new capital increases, for a…
The peer-reviewed journal Frontiers in Microbiology has just published an article by Dr. Pere-Joan Cardona, scientific advisor of Archivel Farma, which analyzes the current state of research on therapeutic vaccines against tuberculosis. “The…
The prestigious magazine Plos One has just published the article “Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent…